Hendrikje Geesje Steenbergen

Title: Hendrikje Geesje Steenbergen: Innovator in Hepatocyte Research

Introduction

Hendrikje Geesje Steenbergen is a notable inventor based in Edmonton, Canada. She has made significant contributions to the field of hepatocyte research, particularly in the development of methods for producing cells that exhibit a primary human hepatocyte phenotype. Her work is crucial for advancing our understanding of liver-related diseases and the development of antiviral drugs.

Latest Patents

Hendrikje holds a patent titled "Methods for producing cells having a phenotype of a primary human hepatocytes and compositions." This patent outlines innovative methods and compositions related to in vitro cultures of human hepatocyte cell lines. These cell lines are particularly valuable as they are susceptible to infection by hepatotrophic viruses, such as HCV or HBV, and support both viral replication and high levels of viral particle production. Such in vitro cultures are essential for the production and study of hepatotrophic viruses, as well as for screening antiviral drugs and assessing drug metabolism.

Career Highlights

Hendrikje is affiliated with the University of Alberta, where she conducts her research. Her work has garnered attention for its potential applications in medical research and drug development. With her expertise, she has contributed to the advancement of knowledge in the field of hepatology.

Collaborations

Hendrikje has collaborated with esteemed colleagues, including D Lorne Tyrrell and Michael A Joyce. These collaborations have further enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Hendrikje Geesje Steenbergen is a pioneering inventor whose research in hepatocyte cell lines is paving the way for advancements in the study of liver diseases and antiviral therapies. Her contributions are invaluable to the scientific community and hold promise for future medical breakthroughs.